Evidence map›Paper›PMID 31341157›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Investigation of Insulin-Like Growth Factor-1 (IGF-1), P53, and Wilms' Tumor 1 (WT1) Expression Levels in the Colon Polyp Subtypes in Colon Cancer.

Ali Aslan, Havva Erdem, Muruvvet Akcay Celik, Arzu Sahin, Soner Cankaya

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Genetic Polymorphisms of theJournal of kidney cancer and VHL · 2021
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ali AslanDepartment of Physiology, Faculty of Medicine, Ordu University, Ordu, Turkey.
Havva ErdemDepartment of Pathology, Faculty of Medicine, Ordu University, Ordu, Turkey.
Muruvvet Akcay CelikDepartment of Pathology, Faculty of Medicine, Ordu University, Ordu, Turkey.
Arzu SahinDepartment of Physiology, Faculty of Medicine, Usak University, Usak, Turkey.
Soner CankayaDepartment of Sports Management, Faculty of Sport Sciences, Ondokuz Mayis University, Samsun, Turkey.
Ordu University · TROndokuz Mayıs University · TRUsak University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND There is no study in the literature investigating the expression levels of WT1, p53, and IGF-1 in colon polyp subtypes. In this study, we aimed to investigate the expression levels of IGF-1, p53, and WT1 in colon polyp subtypes and to determine whether expression levels are correlated with each other. MATERIAL AND METHODS Tissue specimens were obtained from 105 patients (80 men, 25 women; age range, 30-91 years) who underwent surgical resection for colorectal cancer (CRC) at Ordu University School of Medicine, Department of Pathology between January 2015 and 2017. Parameters such as age, sex, region of origin, and pathological diagnosis type were determined. The preparations were immunohistochemically stained with corresponding markers. RESULTS The results of the study showed that there was a statistically significant relationship between WT1 expression (negative - positive) in polyps and the place where the sample was taken (P=0.011). There is a positive relationship between P53 staining score (0-3) and positive frequency of IGF-1 (60.9-85.7%). There was a statistically significant change in P53 scores and location (P=0.006, p=0.015, respectively). As the P53 score of the polyps increased (0 to 3), the rate of adenomatous (34.8-78.4%) increased, so a positive relationship was found. WT1 and IGF-1 gene expression was associated with tumor location, p53 staining score, and sex. CONCLUSIONS WT1 and IGF-1 are appropriate markers for CRC, and WT1 expression in CRC primary tumors especially could be a novel independent marker for prognosis and tumor progression.

Indexed as

AdultAgedAged, 80 and overColonic NeoplasmsColonic PolypsFemaleGene ExpressionHumansInsulin-Like Growth Factor IMaleMiddle AgedPrognosisPromoter Regions, GeneticRNA, MessengerTranscriptomeTumor Suppressor Protein p53IGF1 protein, humanInsulin-Like Growth Factor IRNA, MessengerTP53 protein, humanTumor Suppressor Protein p53WT1 protein, humanWT1 Proteins

Identifiers

PMID31341157
PMCPMC6676992
OpenAlexW2964170316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.